1. Home
  2. PMN vs VIRC Comparison

PMN vs VIRC Comparison

Compare PMN & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$4.14

Market Cap

84.1M

Sector

Health Care

ML Signal

N/A

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

N/A

Current Price

$6.29

Market Cap

97.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
PMN
VIRC
Founded
2004
1950
Country
Canada
United States
Employees
N/A
731
Industry
Pharmaceuticals and Biotechnology
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
84.1M
97.7M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
PMN
VIRC
Price
$4.14
$6.29
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $42.75
N/A
AVG Volume (30 Days)
★ 333.3K
22.1K
Earning Date
11-12-2026
12-07-2026
Dividend Yield
N/A
★ 1.68%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.37
Revenue
N/A
★ $199,652,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.23
P/E Ratio
★ N/A
$16.78
Revenue Growth
★ N/A
N/A
52 Week Low
$0.29
$5.16
52 Week High
$27.40
$7.46

Technical Indicators

Market Signals
Indicator
PMN
VIRC
Relative Strength Index (RSI) 33.11 43.23
Support Level N/A $5.93
Resistance Level $15.05 $6.22
Average True Range (ATR) 1.26 0.16
MACD -0.41 -0.03
Stochastic Oscillator 14.81 35.40

Price Performance

Historical Comparison
PMN
VIRC

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

Share on Social Networks: